# Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients

> **NCT01270347** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 282 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** MP-376 (Levofloxacin Solution for Inhalation)
- **DRUG:** TIS (Tobramycin Inhalation Solution)

## Key facts

- **NCT ID:** NCT01270347
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-10
- **Final completion:** 2013-06
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2024-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01270347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01270347, "Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01270347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*